Carole Ho

Carole Ho is a declared insider at 2 companies (senior executive); the most frequent names are Denali Therapeutics Inc. and Royalty Pharma plc. We count 32 filings; the first trade dates from 19 August 2021 and the latest from 12 August 2025.

On the market, this insider has only sold: 24 sales, €1.9M in total. Besides market trades, the filings include 6 share grants and 2 option exercises. So far in 2025, the count stands at no purchases and 2 sales.

Most recently, on 14 August 2025, the filings show an open-market sale worth €34k in Denali Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.